Mir-204 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells by Targeting Bone Morphogenetic Protein 2

Xiaofeng Jiang,Zuofu Zhang,Tao Peng,Guangda Wang,Qiang Xu,Guangrun Li
DOI: https://doi.org/10.3892/mmr.2019.10791
IF: 3.423
2019-01-01
Molecular Medicine Reports
Abstract:Mesenchymal stem cells (MSCs) are used to investigate regeneration and differentiation. MicroRNA-204 (miR-204) in involved in the Runt-related transcription factor 2/alkaline phosphatase/bone morphogenic protein 2 (Runx2/ALP/BMP2) signaling pathway that regulates bone marrow mesenchymal stem cell (BMSC) differentiation; however, the mechanisms underlying the effects of miR-204 are yet to be determined. The aim of the present study was to investigate the effects of miR-204 on BMSC differentiation. BMSCs were derived from rat bone marrow. The expression levels of Runx2, ALP and BMP2 were measured via reverse transcription-quantitative polymerase chain reaction and western blot analyses following transfection of BMSCs with miR-204 agomir or BMP2 expression vector. The ability of the miR-204 gene to directly bind BMP2 mRNA was assessed using dual-luciferase assays. Ossification was measured via alizarin red stain assays. It was observed that the expression levels of Runx2 and ALP increased over time, whereas those of miR-204 decreased; additionally, miR-204 agomir upregulation inhibited the expression of Runx2, ALP and BMP2 in BMSCs. It was revealed that miR-204 directly interacted with BMP2 mRNA, and that transfection with miR-204 agomir suppressed ossification in BMSCs by targeting the BMP2/Runx2/ALP signaling pathway.
What problem does this paper attempt to address?